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Purpose: Primary open angle glaucoma (POAG) is a leading cause of irreversible blindness on a global level. Researchers
have yet to specify the exact mechanisms of POAG; the respective relationships between POAG and elevated intraocular
pressure (IOP), as well as optic neuropathy, remain particularly unclear. It is known, however, that the expression profile
for some proteins in the aqueous humor (AH) changes in some diseases, and that AH changes play important roles in
elevated IOP. To identify the possible roles of these AH proteins in POAG, a proteomic analysis of the AH compositions
of POAG patients’ eyes was performed and compared with those derived from paired, non-POAG cataract (control) eyes.
Methods: We used Bradford’s method to determine total protein concentration in AH, and analyzed separation profiles
via two-dimensional (2D) gel electrophoresis. We used silver stain to determine gel proteins, and analyzed separation
profiles to assess spot density differences between POAG and non-POAG patients. These gel spots were isolated and
identified via mass spectrometry. Prostaglandin H2 D-isomerase (PGDS) in AH were analyzed by western Blotting.
Results: There was no significant difference between the total protein concentration in AH of POAG patients and that in
AH of non-POAG patients. A total of seven spots were increased in 2D gels from POAG patients. The spots were derived
from PGDS, caspase 14 precursor, transthyretin, cystain C, albumin precursor, and tranferrin. And PGDS in AH from
patients was more than from controls.
Conclusions: The protein composition in AH was significantly different in POAG patients versus non-POAG patients.
The identified proteins could be a potential biomarker for POAG and may play a role in the mechanisms of elevated IOP
and optic neuropathy in POAG.
Glaucoma  is  a  leading  cause  of  irreversible  visual
impairment and blindness on a global level [1]. Primary open
angle glaucoma (POAG), a common type of glaucoma, is
progressive  optic  neuropathy  characterized  by  a  distinct
pattern of optic nerve damage and visual field loss. In this type
of  neuropathy  elevated  intraocular  pressure  (IOP)  due  to
increased resistance of AH outflow through the trabecular
meshwork (TM) is one of the most significant risks. However,
the pathogenesis of POAG, especially elevated IOP, is not
well understood.
AH is an important intraocular fluid responsible for the
supply of nutrients to and removal of metabolic wastes from
the  avascular  tissues  of  the  eye  [2].  It  contains  proteins
secreted from anterior segment tissues [3]. It is known that
protein levels in AH vary and change in many eye diseases
[4-8].  Some  protein  changes  in  AH  correlate  with  the
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mechanisms  or  prognoses  of  many  eye  disorders  [9-13].
Previous studies have focused on investigating changes in AH
of POAG patients. It was reported that transforming growth
factor beta 2 (TGFβ2) and plasminogen activator inhibitor-1
(PAI-1) are elevated in patients with POAG [12,14,15] and
TGFß2 could play roles in POAG through the TGFß receptor
mediated  signal  pathway  [10].  Such  findings  suggest  that
some proteins in AH might be involved in the development of
POAG.
In some previous studies, ELISA was used to examine
the cytokines or some growth factors [7,13]. However, due to
the little sampling volume and low concentration proteins in
AH,  a  wide  range  of  the  protein  studies  was  limited  via
traditional  methods.  Proteomics  has  expanded  the
opportunities to discover disease-specific proteins involved in
AH circulation, and has been used to study eye diseases such
as  acute  corneal  rejection  [16]  and  myopia  [17].  The
proteomic techniques used include protein separation by two-
dimensional gel electrophoresis (2-DE) and characterization
by mass spectrometry of peptides, amino acid sequencing and
bioinformatics  analysis.  High  resolution  two-dimensional
(2D)  PAGE  (PAGE)  is  a  technique  for  analyzing  several
Molecular Vision 2010; 16:2839-2846 <http://www.molvis.org/molvis/v16/a304>
Received 13 May 2010 | Accepted 14 December 2010 | Published 18 December 2010
© 2010 Molecular Vision
2839hundred proteins in tissues, fluids or cells using only a few
microliters of sample, and is therefore theoretically ideal for
analyzing limited volumes of AH.
In this study, we investigated the differential proteomes
in five POAG patients (patients) as well as in matched, non-
POAG cataract patients (controls). Abnormal expressions and
distributions  of  proteins  from  AH  were  identified  and
evaluated in age-paired clinical specimens. It is possible to
achieve  a  better  understanding  of  the  molecular  events
involved in POAG development, and generate essential data
needed for elaborating more effective strategies designed to
help identify new biomarkers and/or treatments.
METHODS
Sample collection: We collected AH samples at the Beijing
Tongren Eye Center, Capital Medical University, China. We
obtained an informed consent from each patient. During the
period from October 2005 to May 2006, we collected AH
samples from five patients with POAG (patients) and from
five cataract patients without POAG (controls).
The glaucoma patients had uncontrolled IOP despite the
use  of  well  tolerated  medical  therapy.  They  experienced
moderate or severe visual field defects and optic disc cupping.
We found that the control cases had normal IOP (less than
20 mmHg in at least two measurements separated by more
than one day) and were undergoing routine senile cataract
surgery for visual rehabilitation. In addition, the glaucoma
patients and the control cases were age- and gender-matched.
Case  exemptions  included  patients  with  other  ophthalmic
diseases, systemic diseases (i.e., diabetes mellitus, arthritis),
and patients who had undergone laser or intraocular surgery.
The  study  followed  the  tenets  of  the  Declaration  of
Helsinki, and informed written consent was obtained from all
patients  and  controls  after  we  explained  the  nature  and
possible consequences of the study. The study protocol was
approved  by  the  Medical  Ethical  Committee  of  Beijing
Tongren Hospital, Capital Medical University, Beijing.
All  AH  samples  were  obtained  before  surgery.
Approximately 100~200 μl AH was collected by a 26 gauge
ophthalmic cannula under a binocular microscope. The AH
was  immediately  stored  in  aliquots  of  50  μl  in  1.5  ml
microtubes at −80 °C until further analysis.
Total protein quantization: Total AH protein concentration
was determined according to the Braford method (Bio-Rad
Laboratories,  Hercules,  CA)  following  the  manufacture’s
protocol as dictated in a previous study [17].
Two-dimensional  gel  electrophoresis:  The  principle
procedure for running 2D gels has been described in detail in
our previous study [17]. We solubilized 45 ml of the AH
samples in 55 μl lysis solution and 100 μl rehydration solution,
to  achieve  a  total  volume  of  AH,  lysis  solution,  and
rehydration solution resulting in 200 μl. We used the final
solution  to  rehydrate  immobilized  pH  gradient  stripes
overnight  with  linear  pH  3–10  at  a  length  of  110  mm
(Immobilize  Drystripes;  Amersham  Biosciences  Inc.,
Amersham,  UK).  For  the  first  dimension,  we  performed
isoelectric focusing on an Ettan Multiphor flat bed unit with
minor  modifications  of  the  manufacturer’s  instructions
(Amersham  Biosciences  Inc.,  Amersham,  UK).  For  the
second  dimension,  we  separated  samples  via  PAGE  on  a
separating gel (1 mm thickness, 12% SDS gel; Hoefer SE600
Ruby, Amersham Biosciences Inc.). We applied a 20 mA
constant current per gel, and ran the gel until the dye reached
the approximate bottom.
The separated proteins within the gels were fixed over a
2 h period in a 40% ethanol, 10% acetic acid solution. We then
silver  stained  the  gel  proteins  according  to  manufacturer
protocol (Silver stain plus kit; BioRad).
Analysis  of  two-dimensional  gels:  The  stained  gels  were
scanned with an Imagescanner (Amersham Biosciences Inc.)
and  analyzed  with  Imagemaster  2D  platinum  software
(Amersham Biosciences Inc.). We matched the gels according
to the number of user-defined landmarks on each gel. Each
spot was quantified according to the % volume of the stained
spot. We chose to work only with spots that showed greater
than two ratios in % volume between patients and controls.
The differences in the spot % volumes were compared with
Mann–Whitney test.
Protein  Identification  by  liquid  chromatography-mass
spectrometry  (LC  MS/MS):  The  principle  procedure  for
protein  identification  has  been  described  in  detail  in  our
previous study [17]. We proteolyzed the gel pieces with 20 ng
of modified trypsin (Promega Biotech Co., Ltd, Madison, WI)
in  25  mM  ammonium  bicarbonate  (AmBic)  overnight  at
37 °C. We then collected supernatant, and further extracted
peptides  in  0.1%  formic  acid,  60%  acetonitrile.  Peptide
extracts were vacuum-dried and resuspended in 20 ml of 0.1%
formic acid solution for mass analysis. We performed a LC-
MS/MS  analysis  in  a  linear  trap  quadrupole  (LTQ;
(ThermoFinnigan, San Jose, CA) coupled online with a nano-
liquid chromatography (Nano LC) system. We searched all
tandem spectra against a H. sapiens NCBI reference database
(human.ncbi) using SEQUEST (version 2.7). Results were
filtered by Xcorr (the cross-correlation value from the search)
+1>1.9,+2>2.5,+3>3.75, sp>500, ∆cn (the Delta Correlation
value) >0.1, Rsp<=5. Every protein identified matched at least
two peptides.
Prostaglandin   H2   D-isomerase   (PGDS)  detection  using
western blotting:The existence of PGDS proteins in aqueous
humor of glaucoma patients was confirmed using western
blotting.  AH  was  separated  on  10%  SDS–PAGE  and
transferred onto a 0.2 μm polyvinylidene fluoride membrane
(Millipore, Molsheim, France) at 220 mA for 2 h in a Bio-Rad
Transblot electrophoretic transfer cell (Bio-Rad). The non-
specific reaction were blocked with 5% non-fat milk in TBS,
the membrane was washed in TBS and incubated with anti-
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2840PGDS antibody (0.3 μg/ml), followed by three washing with
TBST and incubation with horseradish peroxidase-conjugated
mouse  anti-rabbit  immunoglobulin  (1:4,000;
DakoCytomation,  Glostrup,  Denmark).  The  PGDS-anti-
PGDS complex was chemoluminescence was recorded on
Fuju X-ray film (Fuji Photo Film Co. Ltd, Tokyo, Japan).
Statistics: We used SPSS Version 11.0 software (SPSS Inc,
Chicago, IL) to calculate p-values achieved using the Mann–
Whitney test for all data obtained. A p<0.05 was required for
the results to be considered statistically significant.
RESULTS
A total of 10 AH samples were included in this study, five
from  POAG  patients  (mean  age  43.60±12.58  years,  three
males  and  two  females)  and  five  from  age-  and  gender-
matched non-POAG cataract patients (mean age 49.80±5.89
years,  three  males  and  two  females).  There  ware  no
statistically significant differences between the two groups
with regard to age (p=0.55). Clinical data from the 10 patients
are summarized in Table 1.
Protein content in AH from patients and controls: The
mean total protein level in AH from POAG patients was
0.4382±0.1675 mg/ml (Range=0.2796~0.6517 mg/ml) while
that  from  control  patients  was  0.3124±0.0567  mg/ml
(range=0.2484~0.3984  mg/ml;  Table  2).  Although  the
difference between POAG patients and control patients was
not statistically significant (p=0.31) total protein levels in
POAG patients were greater than that of control patients.
Two-dimensional gel electrophoresis patterns: Figure 1
shows a representative gel from a patient (Figure 1A; patient
number 1 in Table 1) and a gel from a control subject (Figure
1B; control number 1 in Table 1). Gels from POAG patients
(Figure 1A) displayed more spots and more intensely silver
stained spots than in gels from control patients (Figure 1B).
There were significant differences in relative spot volumes (%
volume) between POAG patients and control patients. The gel
patterns from POAG patients showed greater % volumes than
those of control patients (Table 3). No protein spots were
found to be downregulated in POAG patients as compared
with control patients.
Identification of proteins: Based on the above results, we
isolated the seven protein spots for further analysis. Each spot
was  acquired  from  the  gel  and  digested  extensively  with
trypsin. The resulting peptides were applied to a nanoLC MS/
MS  for  identification.  Three  peptides  were  captured  and
measured in spot 1, showing a significant protein increase in
POAG patients. Figure 2 shows a typical MS/MS spectrum of
its  parent  ion  m/z=1911.10  (sequence:
AQGFTEDTIVFLPQTDK). Many “y” and “b” series ions
from this peptide were clearly identified in this spectrum.
Sequence  searching  indicated  that  this  peptide  was  from
human  prostaglandin  H2  D-isomerase  (PGDS).  The
remaining two peptides identified from protein spot 1 were
also  located  in  PGDS.  The  total  sequence  coverage  was
17.40%.
Using  the  same  methods,  protein  spot  2  showed  a
significant  peptide  increase  in  POAG  patients,  and  was
identified as caspase 14 with a sequence coverage of 21.10%.
Significantly increased protein spots 3, 4, 5, 6, and 7 were
identified as transthyretin, albumin, Cystain C, albumin, and
transferrin,  with  sequence  coverages  of  48.30%,  3.30%,
18.50%, 4.27%, and 4.20% respectively.
Western blotting analysis: Anti-PGDS antibody-positive
protein was present in AH. Immunoreactive protein strip of
TABLE 1. DATA FROM POAG PATIENTS AND CONTROLS.
Group Number Age Sex IOP (mmHg) C/D ratio
Patient 1 51 F 18 0.8
  2 32 M 25 0.6
  3 55 F 18.5 0.6
  4 67 M 16 0.7
  5 52 M 21 0.5
Control 1 52 F 13.8 0.3
  2 40 M 12.4 0.1
  3 53 F 10.9 0.2
  4 68 M 12.9 0.3
  5 49 M 16.7 0.1
TABLE 2. MEASUREMENT OF TOTAL PROTEIN IN AH FROM PATIENTS AND CONTROLS.
Group Total protein (mg/ml) p-value
Patients 0.4382±0.1675 0.31
Controls 0.3124±0.0567  
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2841AH from POAG patients was more than that from controls. It
suggested that PGDS in AH from POAG patients be up-
regulated compared with that from controls (Figure 3).
DISCUSSION
Although POAG has been widely considered a multifactorial
disease, IOP is the most important known risk factor for the
development  of  glaucomatous  optic  nerve  damage  [18].
Reducing IOP can still be considered the most beneficial
treatment in terms of halting visual field damage progression,
even in normal pressure glaucoma. However, the mechanisms
of elevated IOP have not been fully elucidated. At present, it
is well known that elevated IOP could result from a variety of
cell deaths in the trabecular meshwork [19]. AH, the circulated
intraocular fluid, includes many kinds of cytokines, which
could likely play significant roles in the trabecular meshwork.
Most recent insights regarding POAG have come from
studies on animal models. Other studies of AH typically focus
only on proteins. Grus et al. [20] has studied transthyretin
changes  in  AH  of  POAG  using  surface  enhanced  laser
desorption/ionization-time  of  flight-mass  spectrometry
(SELDI-TOF-MS) ProteinChip arrays and two-dimensional
electrophoresis. In the study, it was known that the protein in
AH was very low and that protein amount is affected by many
factors, such as age, gender, and so on. If AH samples were
pooled for analysis, it is possible that some subtle protein
changes would be neglected. Therefore, in this study, we
directed our attention to proteins in the AH collected directly
from  patients  and  analyzed  AH  protein  changes  strictly
between  POAG  patients  and  paired  non-POAG  control
patients. Such information might offer new insights to reveal
the mechanism of POAG and identify potential biomarkers of
this condition.
In this study, we compared AH proteins between POAG
patients and non-POAG patients (as controls). The patterns of
2D electrophoresis gels in POAG patients were different from
those of control patients, which indicated that the protein
content  in  the  AH  changes  with  POAG  development.
However,  the  origin  and  function  of  AH  proteins  is  still
unknown. Results from previous studies have implicated that
AH  proteins  could  activate  signaling  cascades,  which
subsequently regulate cellular functions including mitosis,
differentiation, motility and apoptosis. Such proteins play a
vital  role  in  corneal  wound  healing,  mediating  the
proliferation  of  epithelial  and  stromal  tissue  and  affect
remodeling of the extracellular matrix (ECM).
In this study, we suggest that alterations in proteins could
possibly  contribute  to  the  pathologic  changes  and
complications of POAG in two ways - by directly affecting
trabecular meshwork or as a response to elevated IOP.
First, we observed a significant increase of PGDS in our
POAG patients and proved that by western blotting analysis.
At present, the function of PGDS in ocular tissues is not clear.
PGDS is responsible for the biosynthesis of prostaglandin D2
in the central nervous system and the genital organs and is
secreted into the cerebrospinal fluid and the seminal plasma
as beta-trace. It is a bifunctional protein that acts as both a
retinoid  transporter  and  a  prostaglandin  D2-producing
enzyme [21]. Elevated PGDS levels have been observed in
the serum of patients with renal impairment, diabetes mellitus,
and hypertension. Recently, we demonstrated the ability of
PGDS to induce apoptosis in a variety of cell types including
epithelial cells, neuronal cells, and vascular smooth muscle
cells [22,23]. Therefore, we suggest that PGDS might mediate
the apoptosis of trabecular meshwork.
Figure  1.  Silver-stained  2D  gels  of
AH.A and B show representative gels
from a patient (A: patient number 1 in
Table1) and a gel from a control subject
(B: control number 1 in Table1). Total
protein concentration in AH was 0.3217
mg/ml from the patient and 0.2924 mg/
ml  from  the  control.  Arrows  and
numbers  show  8  spots  in  the  patient
sample  with  volumes  significantly
increased by values greater than 2 fold
in the patients. The identities of the spots
were derived from prostaglandin H2 D-
isomerase (PGDS; spot 1), caspase 14
precursor  (spot  2  and4),  transthyretin
(spot  3  and  5),  cystain  C  (spot  6),
albumin  precursor  (spot  7),  and
tranferrin (spot 8).
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2843Second, there were few reports about caspase 14 in eyes.
Caspase-14  is  a  unique  member  of  the  evolutionarily
conserved family of cysteinyl aspartate-specific proteinases,
which are mainly involved in inflammation and apoptosis
[24].  Previous  studies  demonstrated  that  caspase  8  and
caspase 9 are the main kinds of caspase that play roles in the
apoptosis of ocular tissues. According to this study, caspase
14 might be involved in the apoptosis of ocular tissues by
either directly mediating or inducing caspase 8 and caspase 9
activation.
In this study, we also observed a significant increase of
transthyretin (TTR) and cystain C in our POAG patients. It
was similar to the changes in cerebrospinal fluid (CSF) of
Figure 3. Western blotting analysis of PGDS in AH. The left lane is
a sample from a control and the right lane is a sample from a POAG
patient.
Alzheimer  disease  (AD).  It  suggested  POAG  has  similar
mechanisms  as  AD,  which  is  a  progressive,
neurodegenerative disease [20,25]. In addition, Grus et al.
[20] reported that transthyretin was highly abundant in the AH
of glaucoma patients, similar to our results.
In addition, we observed elevated transferrin in the AH
of POAG. We suggest it was a response to elevated IOP.
Transferrin was related to the point of inflammation [26],
which usually occurs due to high IOP [27].
In our experiments, we identified additional spots, which
might  be  derived  from  albumin,  according  to  the
characterization and a previous report [16]. However, the
albumin fragments we obtained were different in pI and/or
molecular  weight.  While  we  do  not  have  a  complete
explanation for this finding, we speculate that it could be due
to the degradation of albumin pathways in the AH our POAG
patients.
In addition, the mean total protein level in AH from
POAG patients (0.4382 mg/ml) was greater than that of non-
POAG control patients. However, there was no significant
statistical difference. We suggest that it is due to high SD in
the POAG patients.
In conclusion, the results of our study revealed that the
proteomic  composition  of  AH  was  significantly  different
between  POAG  and  control  conditions.  The  proteins
identified  could  play  roles  in  the  apoptosis  of  trabecular
meshwork  and  serve  as  potential  biomarkers  for  POAG
development.
Figure  2.  MS/MS  spectrum  of
prostaglandin H2 D isomerase(PGDS).
The  protein  peptide
AQGFTEDTIVFLPQTDK  ([M
+H]2+=1911.10)  was  identified  using
this  spectrum,  which  showed  many
characteristic y and b series ions.
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